This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: [email protected].
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/q1-1-apr-to-30-jun-2024-annb-and-ypa-screening-kpi-data/young-person-and-adult-screening-kpi-data-q1-summary-factsheets-1-april-to-30-june-2024
This report should be read in conjunction with the full KPI data tables published each quarter.
Please note that the data presented for previous time periods may be impacted by the COVID-19 pandemic. As a result, time series trends should be interpreted with caution.
1. Abdominal aortic aneurysm screening
1.1
KPI AA2: Coverage: initial screen
AA2 (standard code AAA-S04) shows the proportion of eligible men who are tested. National performance of AA2 (see standard AAA-S04) in quarter 1 2024 to 2025 was 26.1%.
Threshold
Q1
Q2
Q3
Q4
Acceptable Threshold
≤ 18.0%
≤ 38.0%
≤ 56.0%
≤ 75.0%
Achievable Threshold
≤ 21.0%
≤ 42.0%
≤ 64.0%
≤ 85.0%
Quarter 1 performance
Reporting period
Numerator
Denominator
Performance %
Quarter 1 2024 to 2025
89,115
341,525
26.1%
Region
Performance %
East of England
30.1%
London
17.2%
Midlands
30.0%
North East and Yorkshire
18.4%
North West
28.0%
South East
28.3%
South West
32.6%
England
26.1%
1.2
KPI AA3: Coverage: annual surveillance screen
AA3 (standard code AAA-S05) shows the proportion of annual surveillance appointments due where there is a conclusive scan within 6 weeks either side of the due date. National performance of AA3 (see standard AAA-S05) in quarter 1 2024 to 2025 was 90.7%.
AA4 (standard code AAA-S06) shows the proportion of quarterly surveillance appointments due where there is a conclusive scan within 4 weeks either side of the due date. National performance of AA4 (see standard AAA-S06) in quarter 1 2024 to 2025 was 93.7%.
Quarter 1 performance
Reporting period
Numerator
Denominator
Performance %
Quarter 1 2024 to 2025
2,700
2,881
93.7%
Region
Performance %
East of England
95.7%
London
86.3%
Midlands
93.8%
North East and Yorkshire
94.8%
North West
93.0%
South East
93.6%
South West
94.5%
England
93.7%
2. Diabetic eye screening
2.1
KPI DE1: Uptake: Routine digital screening
DE1 (standard code DES-S07) shows the proportion of those offered routine digital screening (RDS) who attend a RDS event where images are captured. DE1 is an annual rolling figure. National performance of DE1 (see standard DES-S07) in quarter 1 2024 to 2025 was 81.8%.
Quarter 1 performance
Reporting period
Numerator
Denominator
Performance %
Quarter 1 2024 to 2025
2,591,597
3,169,720
81.8%
Region
Performance %
East of England
85.2%
London
80.6%
Midlands
78.3%
North East and Yorkshire
81.7%
North West
79.0%
South East
85.3%
South West
86.0%
England
81.8%
2.2
KPI DE2: Test: Timeliness of results letters
DE2 (standard code DES-S10) shows the proportion of eligible people with diabetes attending for diabetic eye screening, digital surveillance or slit lamp biomicroscopy surveillance to whom results were issued within 3 weeks after the screening event. National performance of DE2 (see standard DES-S10) in quarter 1 2024 to 2025 was 97.8%.
Quarter 1 performance
Reporting period
Numerator
Denominator
Performance %
Quarter 1 2024 to 2025
757,187
773,847
97.8%
Region
Performance %
East of England
99.5%
London
93.2%
Midlands
99.7%
North East and Yorkshire
99.4%
North West
94.2%
South East
99.7%
South West
99.6%
England
97.8%
2.3
KPI DE3: Intervention/treatment: Timely consultation for people with diabetes who are screen positive
DE3 (standard code DES-S12) shows the proportion of individuals with an urgent referral who attend a first consultation in the hospital eye service within 6 weeks of their screening or surveillance event. National performance of DE3 (see standard DES-S12) in quarter 1 2024 to 2025 was 67.9%.
Quarter 1 performance
Reporting period
Numerator
Denominator
Performance %
Quarter 1 2024 to 2025
2,059
3,033
67.9%
Region
Performance %
East of England
56.1%
London
74.9%
Midlands
64.8%
North East and Yorkshire
70.0%
North West
64.4%
South East
73.5%
South West
67.0%
England
67.9%
2.4
KPI DE4: Uptake: Repeat non-attenders
DE4 (standard code DES-S08) shows the proportion of eligible people with diabetes who have not attended for routine digital screening in the previous 3 years. National performance of DE4 (see standard DES-S08) in quarter 1 2024 to 2025 was 9.5%.
Quarter 1 performance
Reporting period
Numerator
Denominator
Performance %
Quarter 1 2024 to 2025
213,583
2,250,926
9.5%
Region
Performance %
East of England
7.8%
London
8.4%
Midlands
11.7%
North East and Yorkshire
9.9%
North West
11.3%
South East
7.9%
South West
7.6%
England
9.5%
3. Bowel cancer screening
3.1
KPI BCS1: Uptake
BCS1 shows the proportion of invited people who were screened (adequately participated in FOBt bowel cancer screening), within the invited screening episode (at time of reporting). National performance of BCS1 (standard BCSP-S02) in quarter 1 2024 to 2025 was 65.2%.
Quarter 1 performance
Reporting period
Numerator
Denominator
Performance %
Quarter 1 2024 to 2025
1,206,789
1,851,595
65.2%
Region
Performance %
East of England
67.1%
London
54.2%
Midlands
65.5%
North East and Yorkshire
67.5%
North West
64.3%
South East
67.8%
South West
70.2%
England
65.2%
3.2
KPI BCS2: Coverage
BCS2 (standard code BCSP-S01) shows the proportion of eligible people aged 60-74 who were screened (adequately participated in FOBt bowel cancer screening) in the 30 month period. National performance of BCS2 (standard BCSP-S01) in quarter 4 2023 to 2024 was 71.8%.
BCS2 is collected 6 months (2 quarters) in arrears.
Quarter 4 performance
Reporting period
Numerator
Denominator
Performance %
Quarter 4 2023 to 2024
6,764,895
9,419,903
71.8%
Region
Performance %
East of England
73.0%
London
63.8%
Midlands
71.5%
North East and Yorkshire
73.9%
North West
70.1%
South East
74.1%
South West
75.1%
England
71.8%
4. Breast screening
4.1
KPI BS1: Uptake
BS1 (standard code BSP-S03a) shows the proportion of eligible women who have a technically adequate screen within 6 months of date of first offered appointment. National performance of BS1 (standard BSP-S03) in quarter 1 2024 to 2025 was 66.6%.
Provisional quarterly data should be used with caution to measure performance as it will contain a proportion of women who were invited but have not yet attended the appointment. Data on this indicator will only be accurate 6 months after the end of the reporting period.
Quarter 1 performance
Reporting period
Numerator
Denominator
Performance %
Quarter 1 2024 to 2025
440,529
661,011
66.6%
Region
Performance %
East of England
70.2%
London
58.0%
Midlands
68.1%
North East and Yorkshire
67.1%
North West
68.1%
South East
70.1%
South West
63.6%
England
66.6%
4.2
KPI BS2: Uptake: Screening round length
BS2 (standard code BSP-S04a) shows the proportion of eligible women whose date of first offered appointment is within 36 months of their previous episode (routine programme). National performance of BS2 (standard BSP-S04) in quarter 1 2024 to 2025 was 94.6%.
Quarter 1 performance
Reporting period
Numerator
Denominator
Performance %
Quarter 1 2024 to 2025
438,423
463,209
94.6%
Region
Performance %
East of England
91.2%
London
99.0%
Midlands
93.5%
North East and Yorkshire
93.2%
North West
95.6%
South East
95.0%
South West
95.9%
England
94.6%
5. Cervical screening
5.1
KPI CS1: Coverage under 50 years
CS1 (standard code CSP-S01) shows the proportion of women in the resident population eligible for cervical screening aged 25 to 49 years at end of period reported who were screened adequately within the previous 3.5 years. National performance of CS1 (standard CSP-S01) in quarter 1 2024 to 2025 was 67.1%.
On the 24 June 2024, the NHS Cervical Screening Programme replaced the National Health Application and Infrastructure Services (NHAIS) call and recall IT system with the Cervical Screening Management System (CSMS). The Q1 2024 to 2025 data have been obtained from NHAIS up to the point of transfer to CSMS so does not represent a full quarter and is not directly comparable to previous data. The usual 2-month lag time to ensure that the outcome of all the tests taken in the period are included, has not been applied because the data have been extracted from NHAIS at the point of closure of the NHAIS system. Therefore, the Q1 2024 to 2025 coverage figures reported will be slightly lower than expected.
Quarter 1 performance
Reporting period
Numerator
Denominator
Performance %
Quarter 1 2024 to 2025
7,232,030
10,777,130
67.1%
Region
Performance %
East of England
70.3%
London
60.4%
Midlands
67.4%
North East and Yorkshire
70.2%
North West
67.5%
South East
68.8%
South West
70.8%
England
67.1%
5.2
KPI CS2: Coverage 50 years and above
CS2 (standard code CSP-S02) shows the proportion of women in the resident population eligible for cervical screening aged 50 to 64 years at end of period reported who were screened adequately within the previous 5.5 years. National performance of CS2 (standard CSP-S02) in quarter 1 2024 to 2025 was 74.7%.
On the 24 June 2024, the NHS Cervical Screening Programme replaced the National Health Application and Infrastructure Services (NHAIS) call and recall IT system with the Cervical Screening Management System (CSMS). The Q1 2024 to 2025 data have been obtained from NHAIS up to the point of transfer to CSMS so does not represent a full quarter and is not directly comparable to previous data. The usual 2-month lag time to ensure that the outcome of all the tests taken in the period are included, has not been applied because the data have been extracted from NHAIS at the point of closure of the NHAIS system. Therefore, the Q1 2024 to 2025 coverage figures reported will be slightly lower than expected.
